Trial ID or NCT#
The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
Contact us to find out if this trial is right for you.